Skip to content
12.512.512.5VTVTVT

Drawing based on the label description. No photo yet.

“12.5-mg tablets - Light gray to gray colored round shaped film coated tablets debossed with "12.5" on one side and "VT" on other side”

12 5 VT pill

Pill with imprint 12 5 VT is gray, round, 6 mm and has been identified as Eltrombopag 12.5 mg. It is used for aplastic anemia and idiopathic thrombocytopenic purpura. It is supplied by Biocon Pharma Inc.

Eltrombopag 12.5 mg

Imprint
12 5 VT
Strength
12.5 mg
Used for
Aplastic anemia and idiopathic thrombocytopenic purpura
Color
Gray
Shape
Round
Size
6 mm
Score
No score line
Form
Tablet, film coated
Manufacturer
Biocon Pharma Inc
Drug class
Thrombopoietin receptor agonist
NDC
70377-183, 70377-183-11

Source: the official drug label on DailyMed (US National Library of Medicine). Last checked .

Report a mistake

Please do not include personal health information. For questions about your medicine, ask a pharmacist.

All Eltrombopag pills and guides

What is Eltrombopag used for?

Eltrombopag is used for aplastic anemia and idiopathic thrombocytopenic purpura.

Medicine type
Thrombopoietin receptor agonist
Official uses from the US prescribing label

Treatment of Thrombocytopenia in Patients with Hepatitis C Infection

Eltrombopag tablets are indicated for the treatment of thrombocytopenia in patients with chronic hepatitis C to allow the initiation and maintenance of interferon-based therapy. Eltrombopag tablets should be used only in patients with chronic hepatitis C whose degree of thrombocytopenia prevents the initiation of interferon-based therapy or limits the ability to maintain interferon-based therapy.

Treatment of Severe Aplastic Anemia

  • Eltrombopag tablets are indicated in combination with standard immunosuppressive therapy (IST) for the first-line treatment of adult and pediatric patients 2 years and older with severe aplastic anemia.
  • Eltrombopag tablets are indicated for the treatment of patients with severe aplastic anemia who have had an insufficient response to immunosuppressive therapy.

Limitations of Use

  • Eltrombopag tablets are not indicated for the treatment of patients with myelodysplastic syndromes (MDS).
  • Safety and efficacy have not been established in combination with direct-acting antiviral agents used without interferon for treatment of chronic hepatitis C infection.

From the FDA-approved label on DailyMed (published Sep 21, 2026).

Doctors sometimes prescribe a medicine for other reasons too. If you are not sure what yours is for, ask your pharmacist.

Is this your pill? Check every detail

  • One side shows 12.5 and the other side shows VT.
  • It is gray, round, 6 mm.
  • Its score line and coating match the details on this page.
  • It came from a pharmacy package that names the same drug.

Ingredients

Active: Eltrombopag Olamine

Inactive: Magnesium Stearate, Mannitol, Cellulose, Microcrystalline, Povidone, Sodium Starch Glycolate Type A Potato, Hypromellose, Unspecified, Polyethylene Glycol 400, Titanium Dioxide, Polysorbate 80

Pills that look similar but are different drugs

Same color and shape, different medicine. This is why the imprint matters.

Other Eltrombopag pills